Milestone Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Buy |
8,507
+234
| +3% | +$43.4K | 0.33% | 55 |
|
|
2025
Q1 | $1.73M | Buy |
8,273
+598
| +8% | +$125K | 0.37% | 58 |
|
|
2024
Q4 | $1.36M | Buy |
7,675
+1,539
| +25% | +$273K | 0.3% | 80 |
|
|
2024
Q3 | $1.21M | Buy |
6,136
+702
| +13% | +$139K | 0.27% | 79 |
|
|
2024
Q2 | $932K | Buy |
5,434
+2,842
| +110% | +$488K | 0.23% | 87 |
|
|
2024
Q1 | $472K | Buy |
2,592
+1,017
| +65% | +$185K | 0.13% | 109 |
|
|
2023
Q4 | $244K | Sell |
1,575
-105
| -6% | -$16.3K | 0.08% | 71 |
|
|
2023
Q3 | $249K | Buy |
1,680
+118
| +8% | +$17.5K | 0.09% | 70 |
|
|
2023
Q2 | $211K | Hold |
1,562
| – | – | 0.09% | 62 |
|
|
2023
Q1 | $249K | Buy |
1,562
+32
| +2% | +$5.1K | 0.14% | 62 |
|
|
2022
Q4 | $227K | Buy |
+1,530
| New | +$227K | 0.14% | 63 |
|